Bladder cancer (BCa) is among the ten most frequent cancers globally. It is the tumor with
the highest lifetime treatment‐associated costs, and among the tumors with the heaviest …

Abstract Manganese dioxide (MnO 2) nanoenzymes/nanozymes (MnO 2-NEs) are 1–100
nm nanomaterials that mimic catalytic, oxidative, peroxidase, and superoxide dismutase …

Simple Summary In our systematic review and meta-analysis of eight observational studies
including a total of 1016 patients, we demonstrated excellent pooled inter-observer …

Objectives (I) To determine Vesical Imaging‐Reporting and Data System (VI‐RADS) score 5
accuracy in predicting locally advanced bladder cancer (BCa), so as to potentially identify …

Bladder cancer (BCa) is the second most common genitourinary and fourth most common
cancer overall in the United States, with an estimated 81,400 newly diagnosed cases …

For nearly 50 years, immunotherapy has been used in patients with bladder cancer in the
form of Mycobacterium bovis Bacillus Calmette-Guerin (BCG), which is still the first-line …

Abstract Purpose The Vesical Imaging-Reporting and Data System (VI-RADS) criteria are
expanding, providing fine differentiation of bladder wall layers involvement. We aimed to …

Precise determination and assessment of bladder cancer (BC) extent of muscle invasion
involvement guides proper risk stratification and personalized therapy selection. In this …

Bladder cancer (BC) is the most common cancer of the urinary tract in the United States.
Imaging plays a significant role in the management of patients with BC, including the …

Objective The purpose of the study was to evaluate the effect of an interactive training
program on the learning curve of radiology residents for bladder MRI interpretation using the …